Dual-targeted delivery of doxorubicin by mesoporous silica nanoparticle coated with AS1411 aptamer and RGDK-R peptide to breast cancer in vitro and in vivo
Author:
Funder
Mashhad University of Medical Sciences
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference52 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J. Clin.,2021
2. Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins;Lovitt;BMC Cancer,2018
3. Preset and future evolution of advsnced breast cancer therapy;Alvarez;Breast Cancer Res.,2010
4. Adjuvant systemic therapies in breast cancer;Hernandez-Aya;Surg Clin North Am,2013
5. Doxorubicin, Treasure Island;Johanson-Arbor,2020
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A novel turn-off Tb3+/ssDNA complex-based time-resolved fluorescent aptasensor for oxytetracycline detection using the powerful sensitizing property of the modified complementary strand on Tb3+ emission;Microchemical Journal;2024-02
2. Functionalization of rice husk‐derived mesoporous silica nanoparticles for targeted and imaging in cancer drug delivery;Journal of the Science of Food and Agriculture;2024-01-05
3. A potent multifunctional ZIF-8 nanoplatform developed for colorectal cancer therapy by triple-delivery of chemo/radio/targeted therapy agents;Journal of Materials Chemistry B;2024
4. Doxorubicin loaded thermostable nanoarchaeosomes: a next-generation drug carrier for breast cancer therapeutics;Nanoscale Advances;2024
5. Targeted co-delivery of FOXM1 aptamer and DOX by nucleolin aptamer-functionalized pH-responsive biocompatible nanodelivery system to enhance therapeutic efficacy against breast cancer: in vitro and in vivo;Drug Delivery and Translational Research;2023-12-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3